发明名称 AZAADAMANTANE ESTER AND CARBAMATE DERIVATIVES, AND METHODS OF USE THEREOF
摘要 <p>PROBLEM TO BE SOLVED: To provide compounds that interact selectively withα7-containing neuronal nicotinic receptors (NNRs),α4β2 NNRs, or bothα7 andα4β2 NNRs to effectively treat mild cognitive impairment, age-associated memory impairment (AAMI), senile dementia, AIDS dementia, Pick's disease, dementia associated with Lewy bodies, dementia associated with Down's syndrome, amyotrophic lateral sclerosis, Huntington's disease, smoking cessation, schizoaffective disorder, bipolar and manic disorders, diminished CNS function associated with traumatic brain injury, acute pain, post-surgical pain, chronic pain, inflammatory pain, and the like.SOLUTION: This invention relates to a compound that is a substituted azaadamantane ester and carbamate derivative shown in formula (I), or a pharmaceutically acceptable salt, amide, or a prodrug.</p>
申请公布号 JP2014205695(A) 申请公布日期 2014.10.30
申请号 JP20140124038 申请日期 2014.06.17
申请人 ABBVIE INC 发明人 MICHAEL R SCHRIMPF;NERSESIAN DIANA L;SIPPY KEVIN B;JI JIANGUO;LI TAO;SHI LEI
分类号 C07D471/18;A61K31/439;A61K45/00;A61P21/02;A61P25/00;A61P25/04;A61P25/14;A61P25/16;A61P25/18;A61P25/24;A61P25/28;A61P25/34;A61P29/00;A61P31/18;A61P43/00 主分类号 C07D471/18
代理机构 代理人
主权项
地址